Article Text

PDF
Image challenge
A 52-year-old woman with ventricular tachycardia
  1. Ana Fidalgo1,
  2. Leticia Fernandez-Friera1,2,
  3. Jorge Solis1,2
  1. 1 HM Hospitales-Centro Integral de Enfermedades Cardiovasculares HM-CIEC, Madrid, Spain
  2. 2 Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain
  1. Correspondence to Dr Jorge Solis, Director of the Heart Valve Unit, HM Hospitales, Madrid 28041, Spain; jsolismartin{at}yahoo.es

Abstract

Clinical introduction A 52-year-old woman with shortness of breath and palpitations was referred to a cardiologist. A 24-hour Holter demonstrated high density (37%) of ventricular premature beats (VPBs) and long runs of non-sustained (eventually sustained) monomorphic ventricular tachycardia (VT) with the same morphology as several VPBs detected in a 12-lead ECG (figure 1A). A transthoracic echocardiogram was performed, and the patient’s evaluation was completed with a functional and gadolinium-enhanced cardiovascular MR (CMR) study (figure 1B,C) to assess structural heart disease. In a follow-up visit, an electrophysiological study (EPS) was performed to identify the origin of VPBs and VT (figure 1D).

Figure 1

(A) A 12-lead ECG. (B) Cine CMR-SSFP (steady-state-free-precession) sequence on a three-chamber view. (C) Inversion-recovery gradient echo CMR pulse sequence for delayed enhancement assessment. (D) Three-dimensional electroanatomic voltage mapping of the left ventricular cavity (cranial left anterior oblique view). CMR, cardiovascular MR.

Question What is the most likely cause of VPBs and VT?

  1. Idiopathic VT in the absence of structural heart disease.

  2. Bileaflet mitral valve prolapse (MVP).

  3. Dilated cardiomyopathy.

  4. Left ventricular non-compaction cardiomyopathy.

  5. Ischaemic cardiomyopathy.

Question

  • ventricular tachycardia
  • mitral regurgitation
View Full Text

Statistics from Altmetric.com

Footnotes

  • LF-F and JS contributed equally.

  • Contributors Conception and design of study, acquisition of data, analysis and/or interpretation of data, approval of the version of the manuscript to be published: AF, LF-F, JS. Drafting the manuscript: AF, LF-F. Revising the manuscript critically for important intellectual content: LF-F, JS.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.